Cargando…

COVID-19 Convalescent Plasma Decreased Oxygen Requirement and Hospital Stay in COVID-19 Hospitalized Patients Including Those with Hematological Malignancies: A Report of 16 Patients

[Image: see text] Introduction In the absence of effective and readily available therapy for COVID-19, immediate interventions to improve its mortality are a public health emergency. COVID-19 convalescent plasma (CCP) carries antibodies against SARS-CoV-2 and represents a promising approach. Studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Moayed, Pal, Priya, Niu, Alex, Zwezdaryk, Kevin, Tatje, Elise, Ko, Leta, Satyavarap, Ishwaria, Jones, Wallace, Nachabe, Adeem, Luk, Alfred, Mushatt, David M, Halvorson, Karin, Denson, Joshua, Simeone, Francesco, Smith, Charles, Davis, Gaynelle, Gill, Sukhmani, McDougal, April, Vigh, Aniko, Peterson, Tim, Ning, Bo, Hu, Tony, Socola, Francisco, Safah, Hana, Saba, Nakhle S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	401.Basic Science and Clinical Practice in Blood Transfusion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330292/ http://dx.doi.org/10.1182/blood-2020-141578

Ejemplares similares

Oxygenation and Inflammatory Markers after Early Covid-19 Convalescent Plasma: A Comparison of Survivors and Non-Survivors
por: Baez Sosa, Valentina, et al.
Publicado: (2021)

COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma
por: Niu, Alex, et al.
Publicado: (2020)

COVID-19 Vaccination Motivation and Hesitancy in Heart Transplant Recipients During a Global Health Crisis
por: Mohney, K.L., et al.
Publicado: (2022)

Correlation between ABO Blood Groups and Disease Severity and Mortality in Hospitalized COVID-19 Patients
por: Ramo, Aula, et al.
Publicado: (2020)

Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience
por: Browning, Sabrina L., et al.
Publicado: (2020)

Phase I and Preliminary Results of a Phase II Study (TERAPLASCoV2) of Convalescent Plasma in Patients with Severe and Life-Threatening Pneumonia Caused By Sars-Cov-2
por: Pérez-Jacobo, Fernando, et al.
Publicado: (2020)

Antibody Response Against Sars-Cov-2 in Convalescent Plasma Donors: Preliminary Results from a Single Center in Midwest Brazil
por: Roberti, Maria do Rosario Ferraz, et al.
Publicado: (2020)

Impact of Blood Group Type on Severity of Disease in COVID-19 Patients
por: Rao, Shivani, et al.
Publicado: (2020)

Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study
por: Khanna, Nina, et al.
Publicado: (2020)

Leveraging the Power of a Healthcare System to Fulfill the COVID Convalescent Plasma Needs Early in the COVID-19 Pandemic
por: Baez Sosa, Valentina, et al.
Publicado: (2020)

Use of Convalescent Plasma in COVID-19 Patients: Guayaquil, Ecuador Experience.
por: Plaza, Carlos, et al.
Publicado: (2020)

The Challenge of Recruiting Convalescent Plasma Donors during the COVID-19 Pandemic: Preliminary Results from a Single Center in Midwest Brazil
por: Roberti, Maria do Rosario Ferraz, et al.
Publicado: (2020)

A National Collaborative Multicenter Phase II Study for Potential Safety Efficacy of Convalescent Plasma to Treat Severe COVID-19 Patients
por: Al Hashmi, Hani, et al.
Publicado: (2020)

Hemorrhage Is a Major Cause of Blood Transfusion in COVID-19 Patients
por: Sanz, Cristina, et al.
Publicado: (2020)

ABO/Rh Blood Group and COVID-19 Infection Severity
por: Hermel, David J, et al.
Publicado: (2020)

Caring for Patients with Sickle Cell Disease during a Pandemic: Continuing to Provide Automated Red Blood Cell Exchange Transfusions in Difficult Times
por: Godby, Richard Curtis, et al.
Publicado: (2020)

Accuracy of efficient data methods to determine the incidence of hospital-acquired thrombosis and major bleeding in medical and surgical inpatients: a multicentre observational cohort study in four UK hospitals
por: Horner, Daniel, et al.
Publicado: (2023)

Development of prospective hospital-based venous thromboembolism registry across India: a study protocol
por: Tabassum, Heena, et al.
Publicado: (2023)

Venous thromboembolism incidence in the Ireland east hospital group: a retrospective 22-month observational study
por: Kevane, Barry, et al.
Publicado: (2019)

Patient self-assessment of hospital pain, mood and health-related quality of life in adults with sickle cell disease
por: Anie, Kofi A, et al.
Publicado: (2012)

Screening for monoclonal B-lymphocyte expansion in a hospital-based Chinese population with lymphocytosis: an observational cohort study
por: Xu, Jiadai, et al.
Publicado: (2020)

Further Observations on the Results of Blood Transfusion in War Surgery
Publicado: (1918)

A Simple and Rapid Method for the Selection of Suitable Donors for Transfusion by the Determination of Blood Groups
Publicado: (1918)

Transfusion with Tested Bloods
Publicado: (1918)

Reticulocytes in donor blood units enhance red blood cell alloimmunization
por: Thomas, Tiffany A., et al.
Publicado: (2023)

Inhibition of GPIb-α-mediated apoptosis signaling enables cold storage of platelets
por: Marini, Irene, et al.
Publicado: (2023)

Anticoagulant therapies for acute venous thromboembolism among a cohort of patients discharged from Canadian urban and rural hospitals
por: Bungard, Tammy J, et al.
Publicado: (2018)

COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality
por: Niu, Alex, et al.
Publicado: (2020)

High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies()
por: Niu, Alex, et al.
Publicado: (2021)

Status of hospital-based blood transfusion services in low-income and middle-income countries: a cross-sectional international survey
por: Barnes, Linda S, et al.
Publicado: (2022)

Symptoms of acute transfusion reactions at a general referral hospital in Kinshasa, Democratic Republic of Congo: a cross-sectional study
por: Musumari, Patou Masika, et al.
Publicado: (2021)

Anticoagulant therapies for acute venous thromboembolism: a comparison between those discharged directly from the emergency department versus hospital in two Canadian cities
por: Bungard, Tammy J, et al.
Publicado: (2018)

Construction and validation of a risk prediction model for perianal infection in patients with haematological malignancies during chemotherapy: a prospective study in a tertiary hospital in China
por: Wang, Yingli, et al.
Publicado: (2023)

Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database
por: Coleman, Craig I, et al.
Publicado: (2015)

Proximal deep vein thrombosis among hospitalised medical and obstetric patients in Rwandan university teaching hospitals: prevalence and associated risk factors: a cross-sectional study
por: Mugeni, Regine, et al.
Publicado: (2019)

Improving safety of unfractionated heparin: a retrospective, quasi-experimental, observational study of the impact of a pocket card and a computerised prescription aid tool in the University Hospitals of Geneva
por: Jimaja, Wedali E, et al.
Publicado: (2022)

Association between PCV13 pneumococcal vaccination and risk of hospital admissions due to pneumonia or sepsis among patients with haematological malignancies: a single-centre retrospective cohort study in Israel
por: Draliuk, Regina, et al.
Publicado: (2022)

Time to detection of anaemia and its predictors among women of reproductive-age living with HIV/AIDS initiating ART at public hospitals, Southwest Ethiopia: a multicentre retrospective follow-up study
por: Belay, Alemayehu Sayih, et al.
Publicado: (2022)

Prevalence of anaemia and its associated factors among HIV-infected adults at the time of ART initiation at Debre Markos Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective cross-sectional study
por: Aemro, Agazhe, et al.
Publicado: (2022)

Pragmatic, double-blind, randomised trial evaluating the impact of red blood cell donor sex on recipient mortality in an academic hospital population: the innovative Trial Assessing Donor Sex (iTADS) protocol
por: Fergusson, Dean A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ku0jhtm9r853rh115u9mmfq6ph